Cryptocurrency is a new class of asset that is gaining both friends and foes. For those who are already in the know, this form of investing pays off some of the best earnings out of all of bonds or stocks. Most likely, the cryptocurrencies you are already familiar with are what seasoned investors and analysts call Phase 1 cryptos.
But have you heard of Phase 2 Cryptos? Probably not. In a recent online presentation, crypto investor and financial analyst Stephen McBride spoke in detail about Phase 2 cryptos. To clean the air, Stephen is one of the most accurate stock pickers in the industry. .
Some of its recent picks include Plug Power (1,746%), Intellia (1,354%), and The Trade Desk (957%). Forbes paid Stephen over $ 10,000 per article for his early research on stocks based on his intelligence and the accuracy of his stock forecast.
In addition to driving ordinary investors to big profits, McBride made his predictions with a consistently high batting average, which amounts to an 88% win rate over the course of a year and a half. Almost 9 out of 10 stocks that he recommends increasing in value. In 2020, he detonated the S&P 500 by 193%.
This means that Stephen is a master of the art of safely generating large returns on stocks. This review covers what he said recently about Phase 2 cryptos and the RiskHedge Venture Program.
What is RiskHedge Venture?
RiskHedge Venture is a premier consulting firm which focuses on identifying the cryptocurrencies with the best potential to increase in value by at least 1000%. Stephen McBride is the managing director of RiskHedge, which believes crypto adoption is just beginning.
This means that investors have enough time and opportunities to get into the crypto space. They can invest in crypto wallets that could yield tenfold or even more using the right strategies. Stephen and his team at RiskHedge are targeting tiny and little-known cryptos. Buying these cryptos today is like buying the starting shares of some mega stocks like Uber or Airbnb when they started.
Learn more about Stephen McBride
A native of Dublin, Ireland, Stephen McBride is a seasoned investor and professional chief analyst at RiskHedge. Stephen worked for a billion dollar financial institution in New Zealand before giving up corporate life. He has traveled the world and lived on four continents.
Currently, Stephen spends his time in Ireland and the United States. At RiskHedge, Stephen has led many investors to several triple-digit gains over the past few months. After the peak of Covid-19 in March 2020, he urged his readers to invest in stocks, just ahead of the biggest rise in stock market history.
The Crypto Phase 2 Summit
In a recent presentation titled The Phase 2 Summit, Stephen McBride spoke more about Phase 2 cryptos. According to Stephen, these cryptos are currently like bitcoins when they are only worth $ 13. Explaining that the first generation of cryptos have generated huge gains since their launch, Stephen explored a new batch of cryptos.
During the presentation, Stephen said that Phase 2 cryptos have the potential to quintuple in a single month as they are still small and undiscovered. The presentation attracted thousands of RiskHedge subscribers who listened to everything they needed to know about explosive cryptos.
Stephen even revealed one of his top picks with ten times as much. He explained that some little-known cryptos might experience predictable frenzy when millions of investors buy them all at the same time. During the summit, Stephen explained how investors can anticipate these frenzies and the easiest way to buy these cryptos when their prices are soaring.
According to Stephen, this is possible because a small group of cryptos is usually hidden from the average investor. Once they make their debut in public, millions of investors buy them all at once, resulting in a buying spree. The situation can lead to a financial reward of 250% or more in just a few days. As new research confirms, they can yield up to 91% on average in just five days.
How RiskHedge Venture Works
RiskHedge is a unique new service that allows people to invest in cryptocurrency in their initial stages. It works the same way venture capitalists invest in start-ups, turning them into millions in the end.
Likewise, RiskHedge Venture allows investors to choose the most attractive Phase 2 cryptos when they are just getting started. Many Phase 2 cryptos trade for pennies or even less. Buying them today is like buying bitcoin when it cost $ 13. Stephen and his team at RiskHedge are identifying tiny undiscovered cryptos while their prices are still in pennies.
Significantly, Stephen and his team only recommend Phase 2 cryptos which can appreciate ten times as much.
What is included in the RiskHedge Venture subscription?
RiskHedge Venture subscription comes with the following:
Special Report # 1: Phase 2 Crypto to Buy Before It’s Listed on Coinbase
According to McBride and his team, this little-known Phase 2 crypto has a potential of 3000% on the upside. Currently, it is only 0.02% of the size of bitcoin and is not yet listed on Coinbase. When it was finally registered on Coinbase, it should witness the same powerful buying pressure that has seen some cryptos gain as much as 12,000%.
Stephen is optimistic that this cryptocurrency will begin trading on Coinbase in the first half of 2022. However, he also warns that its listing on Coinbase could take place much earlier than expected. In this special report, Stephen aims to walk his readers through three easy steps to buy this crypto before listing.
Special Report # 2: Crypto Starter Kit – How to Buy Your First Crypto in 5 Minutes
Through this guide, Stephen aims to show readers how to buy their first crypto asset in just five minutes, even for anyone who has never bought crypto before. Stephen explains the guide’s best, most accessible, and secure way to buy cryptocurrency. It guides readers through a systematic way to purchase any new crypto recommendation.
Special Report # 3: RiskHedge Venture Owner’s Manual
In this crypto handbook, Stephen reveals the keys to his asymmetric investing strategy, allowing investors to make up to 3,000% profit by starting with small initial investments.
The manual explains everything an investor wants to know about blockchain and crypto, in plain English. It also reveals the safest way to protect cryptos.
Overall, Stephen suggests choosing at least one new crypto per month. Most of these choices will be tiny little-known cryptos that are not yet listed on Coinbase. All of them have the potential to explode by ten or more as they approach Coinbase listing.
RiskHedge Venture Subscription Fees and Refund Policy
The official website states that Risk Hedge Venture is available for a one or two year subscription. A one-year RiskHedge Venture membership costs $ 3,000. The two-year subscription costs $ 4,500. The first option guarantees 12 copies of RiskHedge Venture, while the second option provides 24 copies of RiskHedge Venture.
In particular, the program is accompanied by a reimbursement policy. Those who decide RiskHedge Venture is not for them can contact the company within 60 days of joining and get a full credit refund, which they can apply to any other RiskHedge service.
Final word from the risk coverage company
According to Stephen, many Phase 2 cryptos are just getting started. They are unknown to most people. This means that their prices should increase when many people start buying them all at the same time. It works the same as the best venture capital deals.
However, there isn’t enough room for everyone in Phase 2 cryptos. For this reason, Stephen and his team can only accommodate 750 members of the RiskHedge Venture Program. Each founding member of the program is one of the very few investors to have access to these tiny, undiscovered cryptos.
RELATED:Best Business Credit Repair Services That Work in 2021 (Review)
Affiliate Disclosure:
Links in this product review may result in a small commission if you choose to purchase the recommended product at no additional cost to you. This serves to support our research and editorial team and please be aware that we only recommend high quality products.
Warning:
Please understand that the advice or guidelines disclosed here do not even replace, at a distance, sound medical advice from a licensed healthcare provider. Be sure to consult a professional physician before making a purchase decision if you are using any medications or have any concerns as a result of the review details shared above. Individual results may vary because statements made regarding these products have not been evaluated by the Food and Drug Administration. The effectiveness of these products has not been confirmed by FDA approved research. These products are not intended to diagnose, treat, cure or prevent any disease.
Comments are closed.